Jgp Global Gestao De Recursos Ltda. Mirati Therapeutics, Inc. Transaction History

Jgp Global Gestao De Recursos Ltda.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$132.01 - $190.29 $167,916 - $242,048	-1,272 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$132.13 - $177.45 $168,069 - $225,716	1,272 New	1,272 $225,000
Q1 2021 May 11, 2021	SELL	$158.92 - $221.61 $378,229 - $527,431	-2,380 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$162.05 - $240.27 $2,592 - $3,844	-16 Reduced 0.67%	2,380 $523,000
Q3 2020 Nov 12, 2020	SELL	$113.26 - $167.27 $1,245 - $1,839	-11 Reduced 0.46%	2,396 $398,000
Q2 2020 Aug 10, 2020	BUY	$72.01 - $120.39 $173,328 - $289,778	2,407 New	2,407 $275,000
Q1 2020 May 07, 2020	SELL	$69.78 - $116.21 $145,630 - $242,530	-2,087 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$70.76 - $128.86 $147,676 - $268,930	2,087 New	2,087 $269,000
Q2 2019 Jul 19, 2019	SELL	$59.49 - $104.71 $196,079 - $345,124	-3,296 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$43.65 - $78.95 $143,870 - $260,219	3,296 New	3,296 $242,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.